Research Analysts Set Expectations for BEAM FY2025 Earnings
Research analysts at Cantor Fitzgerald decreased their FY2025 earnings per share estimates for Beam Therapeutics in a note issued to investors on Wednesday, February 26th. Cantor Fitzgerald analyst R.
Xometry (NASDAQ:XMTR) Price Target Raised to $20.00
Xometry (NASDAQ:XMTR – Free Report) had its target price upped by Cantor Fitzgerald from $12.00 to $20.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage ...